Citius Pharmaceuticals, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Citius Pharmaceuticals, Inc. (CTXR) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $75.91 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $75.91M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $69.08M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $93.47M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $77.53M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $75.91M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $69.08M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $93.47M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $77.53M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $67.56M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $63.58M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $68.92M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $74.10M 10-Q · filed 2026-08-14 | |
| 2024-06-30 | $86.28M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $79.97M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $85.33M 10-Q · filed 2025-08-12 | |
| 2023-09-30 | $91.43M 10-K · filed 2025-12-23 | |
| 2023-06-30 | $98.30K 10-Q · filed 2024-08-12 | $98.30M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $91.81M 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $101.03M 10-Q · filed 2024-08-12 | |
| 2022-09-30 | $103.43M 10-K · filed 2024-12-27 | |
| 2022-06-30 | $110.34M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $118.20M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $124.56M 10-Q · filed 2023-08-14 | |
| 2021-09-30 | $132.78M 10-K · filed 2023-12-29 | |
| 2021-06-30 | $137.28M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $125.76M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $25.80M 10-Q · filed 2022-08-11 | |
| 2020-10-01 | $33.67M 10-K · filed 2022-12-22 | |
| 2020-09-30 | $33.67M 10-Q · filed 2022-08-11 | |
| 2020-06-30 | $28.74M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $25.22M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $23.15M 10-Q · filed 2021-08-12 | |
| 2019-09-30 | $27.15M 10-K · filed 2021-12-15 | |
| 2014-12-31 | -$823.55K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$741.93K 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |